GATA1 in normal and malignant hematopoiesis - PubMed (original) (raw)
Review
GATA1 in normal and malignant hematopoiesis
John D Crispino. Semin Cell Dev Biol. 2005 Feb.
Abstract
In the late 1980s, several research groups independently discovered the founding member of the GATA family of transcription factors, GATA-1. Each group had evidence that GATA-1 played an important role in erythroid gene expression, but little did they know that it would turn out to be a key regulator of development of not only red blood cells, but of several other hematopoietic cell types as well. Furthermore, few would have guessed that missense mutations in GATA1 would cause inherited blood disorders, while acquired mutations would be found associated with essentially all cases of acute megakaryoblastic leukemia (AMKL) in children with Down syndrome (DS). With respect to the latter disorder, the presence of a GATA1 mutation is now arguably the defining feature of this leukemia. In this review, I will summarize our current knowledge of the role of GATA-1 in normal development, and discuss how mutations in GATA1 lead to abnormal and malignant hematopoiesis.
Similar articles
- Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.
Wechsler J, Greene M, McDevitt MA, Anastasi J, Karp JE, Le Beau MM, Crispino JD. Wechsler J, et al. Nat Genet. 2002 Sep;32(1):148-52. doi: 10.1038/ng955. Epub 2002 Aug 12. Nat Genet. 2002. PMID: 12172547 - Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.
Greene ME, Mundschau G, Wechsler J, McDevitt M, Gamis A, Karp J, Gurbuxani S, Arceci R, Crispino JD. Greene ME, et al. Blood Cells Mol Dis. 2003 Nov-Dec;31(3):351-6. doi: 10.1016/j.bcmd.2003.08.001. Blood Cells Mol Dis. 2003. PMID: 14636651 - Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome.
Gurbuxani S, Vyas P, Crispino JD. Gurbuxani S, et al. Blood. 2004 Jan 15;103(2):399-406. doi: 10.1182/blood-2003-05-1556. Epub 2003 Sep 25. Blood. 2004. PMID: 14512321 Review. - GATA transcription factors in hematologic disease.
Cantor AB. Cantor AB. Int J Hematol. 2005 Jun;81(5):378-84. doi: 10.1532/ijh97.04180. Int J Hematol. 2005. PMID: 16158817 Review.
Cited by
- STAT1 promotes megakaryopoiesis downstream of GATA-1 in mice.
Huang Z, Richmond TD, Muntean AG, Barber DL, Weiss MJ, Crispino JD. Huang Z, et al. J Clin Invest. 2007 Dec;117(12):3890-9. doi: 10.1172/JCI33010. J Clin Invest. 2007. PMID: 18060035 Free PMC article. - A β1-tubulin-based megakaryocyte maturation reporter system identifies novel drugs that promote platelet production.
Seo H, Chen SJ, Hashimoto K, Endo H, Nishi Y, Ohta A, Yamamoto T, Hotta A, Sawaguchi A, Hayashi H, Koseki N, Murphy GJ, Fukuda K, Sugimoto N, Eto K. Seo H, et al. Blood Adv. 2018 Sep 11;2(17):2262-2272. doi: 10.1182/bloodadvances.2018019547. Blood Adv. 2018. PMID: 30206099 Free PMC article. - Phosphorylation of Gata1 at serine residues 72, 142, and 310 is not essential for hematopoiesis in vivo.
Rooke HM, Orkin SH. Rooke HM, et al. Blood. 2006 May 1;107(9):3527-30. doi: 10.1182/blood-2005-10-4309. Epub 2006 Jan 3. Blood. 2006. PMID: 16391009 Free PMC article. - Activator protein-2α functions as a master regulator of multiple transcription factors in the mouse liver.
Li Q, Luo C, Löhr CV, Dashwood RH. Li Q, et al. Hepatol Res. 2011 Aug;41(8):776-83. doi: 10.1111/j.1872-034X.2011.00827.x. Epub 2011 Jun 17. Hepatol Res. 2011. PMID: 21682828 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical